Submitted by Anonymous (not verified) on 26 March 2024 - 16:12
Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), Date of authorisation: 11/03/2021, Revision: 31, Status: Authorised
Source: